标题
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2021-12-11
DOI
10.1021/acs.jmedchem.1c01688
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor
- (2021) Marina Buyanova et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Frequency of Ras Mutations in Cancer
- (2020) Ian A. Prior et al. CANCER RESEARCH
- Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
- (2020) Jay B. Fell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugging all RAS isoforms with one pocket
- (2020) Dirk Kessler et al. Future Medicinal Chemistry
- Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
- (2020) Hao Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo
- (2020) Kotaro Sakamoto et al. Scientific Reports
- Drugging an undruggable pocket on KRAS
- (2019) Dirk Kessler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
- (2019) Brian A. Lanman et al. JOURNAL OF MEDICINAL CHEMISTRY
- The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
- (2018) Rasmus Hansen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
- (2018) Rasmus Hansen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines
- (2018) Sébastien L. Degorce et al. JOURNAL OF MEDICINAL CHEMISTRY
- Salt Bridge in Ligand–Protein Complexes—Systematic Theoretical and Statistical Investigations
- (2018) Rafał Kurczab et al. Journal of Chemical Information and Modeling
- Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity
- (2018) Jay B. Fell et al. ACS Medicinal Chemistry Letters
- Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d
- (2017) Satoshi Sogabe et al. ACS Medicinal Chemistry Letters
- Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere
- (2015) Rainer Wilcken et al. ACS Chemical Biology
- Inhibition of Ras Signaling by Blocking Ras-Effector Interactions with Cyclic Peptides
- (2015) Punit Upadhyaya et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Conformational restriction: an effective tactic in 'follow-on'-based drug discovery
- (2014) Zengjun Fang et al. Future Medicinal Chemistry
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
- (2012) Qi Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
- (2012) T. Maurer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Ras–effector interactions by cyclic peptides
- (2012) Xianghong Wu et al. MedChemComm
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now